Simplifying Global Compliance
EMA Stands Firm on PK Studies for Insulin Biosimilars
Clinical Trials Advisor
The European Medicines Agency has rejected calls from industry to use biosimilar reference products from outside the EU unless they are justified using pharmacokinetic tests.
To View This Article:
Subscribe To Clinical Trials Advisor
Buy This Article Now
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing